New eBook: The role of real-world evidence in FDA approvals. Download now.

The biggest innovation you can make is a better decision.

Aetion Evidence Platform® delivers real-world evidence for life sciences companies, payers, and at-risk providers. We help you answer the high-stakes questions in health care: what works best, for whom, and when. Because better answers lead to better decisions.

Learn more

Real-Time Insights & Evidence

The first and only real-time real-world evidence system.

Learn more

Virtual ISPOR Europe 2020

During Virtual ISPOR Europe 2020, tune into Aetion’s presentation “Comparison of external control arm critiques in regulatory and health technology assessment oncology submissions,” which was awarded a Certificate of Recognition.

Learn more

The Evidence Hub

Want to learn more about real-world evidence? Read up on perspectives, milestones, and best practices in real-world evidence and value-based health care on our blog, the Evidence Hub.

Population Level Analytics for COVID-19

Learn more

Scientific rigor for real-world evidence

As a partner to 13 of the top 20 global biopharma firms, leading payers, and the FDA, Aetion informs the most critical decisions in the industry. Our transparent analyses guide product development, commercialization, and payment innovation into health care’s modern era.

Rapid answers for decisions that matter

Aetion Evidence Platform moves the application of real-world evidence from descriptive analytics to causal conclusions. And it delivers answers within days and weeks—the rapid results needed to improve clinical and financial outcomes. Turn your best available information into insights you can use now.

Trusted evidence for all stakeholders

Our solutions begin with asking the right question and determining the right data from our commercial and academic partners around the world. Then, the analytic workflows of the platform—meeting and setting international scientific standards—enable you to validate assumptions and align stakeholders. Including on value-based care imperatives such as outcomes-based contracting.

Aetion Evidence Platform has been tremendous for us with regards to delivering RWE more efficiently. From an operational perspective, it has helped us generate high quality evidence faster, and allows us to deliver more for our stakeholders.

— Dr. Robert LoCasale

Head of Real World Evidence, Sanofi

The most intriguing part of the Aetion story is the ability to have a very consistent analytic approach that can be applied across multiple data sets.

— Dr. Amy Abernethy (in STAT)

Principal Deputy Commissioner, FDA

Aetion’s rapid turn-around time is critical, as is the fact that their analyses are based on our membership. By using predictive modeling to identify high-risk patients—who will become high-cost—we’re able to quickly engage with providers and health systems to intervene early. This improves outcomes for our highest-risk patient populations.

— Dr. Saira Jan

Director of Pharmacy Strategy and Clinical Integration, Horizon Blue Cross Blue Shield of New Jersey

As part of our digital business transformation, we believe that strategic partnerships will advance our capabilities for rapid analytics. The Aetion Evidence Platform has helped reduce the completion time for UCB’s RWE initiatives by 50%, and has enhanced our capabilities to run multiple concurrent studies.

— Dr. Eddie Lee

Head, US HEOR Strategy, UCB

News & Events

October 15, 2020

BioWorld

Unite and conquer approach finds shared weaknesses of coronaviruses

October 8, 2020

Crain’s New York

Health analytics startup expands partnership with global pharma firm

March 2, 2021

Scope Summit

RWD/RWE discussion

February 17, 2021

2021 Health Datapalooza and National Health Policy Conference

Novel ways of generating and returning evidence to the patient

The Evidence Digest

Subscribe to our newsletter for insights and updates on research and applications for real-world evidence in life sciences and value-based health care.